Search filters

List of works by Marc Espié

18FDG-PET/CT for predicting the outcome in ER+/HER2- breast cancer patients: comparison of clinicopathological parameters and PET image-derived indices including tumor texture analysis

scientific article published on 05 January 2017

A Constitutional Activating MET Mutation Makes the Genetic Link between Malignancies and Chronic Inflammatory Diseases

scientific article published on 19 April 2019

A multicenter randomized phase II study of sequential epirubicin/cyclophosphamide followed by docetaxel with or without celecoxib or trastuzumab according to HER2 status, as primary chemotherapy for localized invasive breast cancer patients

scientific article published on 18 May 2010

Cyclophosphamide dose intensification may circumvent anthracycline resistance of p53 mutant breast cancers

scientific article published on 12 March 2010

Diffusion-weighted MRI in pretreatment prediction of response to neoadjuvant chemotherapy in patients with breast cancer ⬇️

scientific article published on 08 May 2013

Distinct tumor protein p53 mutants in breast cancer subgroups

scientific article

Exquisite sensitivity of TP53 mutant and basal breast cancers to a dose-dense epirubicin-cyclophosphamide regimen

scientific article published in March 2007

High expression of apoptosis protein (Api-5) in chemoresistant triple-negative breast cancers: an innovative target

scientific article published on 12 November 2019

Increased incidence of ERBB2 overexpression and TP53 mutation in inflammatory breast cancer

scientific article published on 01 October 2002

Long-term outcome of the REMAGUS 02 trial, a multicenter randomised phase II trial in locally advanced breast cancer patients treated with neoadjuvant chemotherapy with or without celecoxib or trastuzumab according to HER2 status

scientific article published on 6 March 2017

Molecular apocrine breast cancers are aggressive estrogen receptor negative tumors overexpressing either HER2 or GCDFP15.

scientific article

Ovarian reserve in breast cancer: assessment with anti-Müllerian hormone.

scientific article published on 28 July 2014

Prognostic Impact of Stromal Immune Infiltration before and after Neoadjuvant Chemotherapy (NAC) in Triple Negative Inflammatory Breast Cancers (TNIBC) Treated with Dose-Dense Dose-Intense NAC

scientific article published on 17 September 2020

Prognostic impact of (18)FDG-PET-CT findings in clinical stage III and IIB breast cancer

scientific article

TP53 status and response to chemotherapy in breast cancer

scientific article published on 10 June 2008

Targeting autophagic cancer stem-cells to reverse chemoresistance in human triple negative breast cancer

scientific article

The yield of 18F-FDG PET/CT in patients with clinical stage IIA, IIB, or IIIA breast cancer: a prospective study

scientific article published on 30 August 2011

Triple-negative breast cancer: early assessment with 18F-FDG PET/CT during neoadjuvant chemotherapy identifies patients who are unlikely to achieve a pathologic complete response and are at a high risk of early relapse

scientific article published on 12 January 2012

p53 in breast cancer subtypes and new insights into response to chemotherapy

scientific article published on August 2013

¹⁸F-FDG-PET/CT in staging, restaging, and treatment response assessment of male breast cancer

scientific article published on 17 June 2014

Paulina is supported by:

About Paulina

Help